Kobayashi Pharmaceutical Co., Ltd.

TSE:4967.T

5530 (JPY) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 20,33827,95027,63626,63526,80425,30422,57219,094.61918,75520,05619,66618,85319,82213,17814,55316,27015,80016,03814,00912,769
Depreciation & Amortization 6,0575,3584,8354,1064,1273,4033,5193,499.9913,0713,0953,0962,9693,2314,1554,2564,2123,7642,7822,8132,735
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -6,5796,834-2,143-1,281-4,277-3,697567-2,269-1,959-993-1,421-2,211-1,316-4,649763-1,304-116-5,516-1,425-3,965
Accounts Receivables -3,7818,296-1,5231,588-1,426-3,367-2,969-11,0450-907-2,322213-2,0600000000
Inventory -3,175-1,977-4621,309-1,020-493-5261,147-1,534-1,6511,572-596-1,0184301,389-722-5,907-4,762-4,417-4,174
Accounts Payables -1,3901,240813-984-9934811,5002,32701,9300000000000
Other Working Capital 1,767-725-971-3,194-838-3,2041,0935,302-425658-2,993-1,615-298-5,079-626-5825,791-7542,992209
Other Non Cash Items -1,456-8,228-7,909-5,474-6,565-5,003-4,30810,342.372-5,538-6,713-7,828-10,369-4,487484-4,253-6,329-7,256-4,471-2,238-3,175
Operating Cash Flow 18,36031,91422,41923,98620,08920,00722,35016,09714,32915,44513,5139,24217,25013,16815,31912,84912,1928,83313,1598,364
Investing Activities:
Investments In Property Plant And Equipment -13,569-16,229-4,185-4,149-4,804-3,701-3,205-3,485-4,047-3,678-3,344-2,875-2,092-2,165-2,985-2,791-2,628-1,947-2,285-4,578
Acquisitions Net -11,1713200-11,355-161-2,461-449-2,4442,961-6207004,024-426-412-324-674-1,205047-2,222
Purchases Of Investments -49,352-49,586-49,467-57,891-53,060-55,313-53,651-63,888-83,129-67,563-64,575-73,957-42,435-43,297-28,361-20,389-24,465-7,468-6,926-577
Sales Maturities Of Investments 54,74751,75461,56260,72953,30153,54563,98469,33673,38066,66860,63146,24941,71137,05226,50120,68619,50001,219174
Other Investing Activites -231-254-11910-348-132360-37-97653-371-463134444681,7872,374-2,3881,5313,267
Investing Cash Flow -19,576-14,3127,991-12,656-5,072-8,0627,039-519-10,932-4,540-6,959-26,605-2,929-8,378-4,701-1,381-6,424-11,803-6,414-3,936
Financing Activities:
Debt Repayment 0-1-12-5-570-1-103-41-46-115000-1750-672-136-494-629-1,143
Common Stock Issued 01120-662361352911,62400000020491194830
Common Stock Repurchased -12,000-14,056-3,9430-8,0140-5,068-8,054-8,109-1,501-2-1-10-1-1,675-3-8-1,219-16
Dividends Paid -7,223-6,509-6,251-5,784-5,333-4,818-4,343-3,919-3,837-3,552-3,521-3,357-2,785-2,703-2,374-2,303-3,184-1,569-1,373-874
Other Financing Activities -240-194-183-230-2173-10368169-102-286-371-506-2,2765601-2,078-5561,719-1,336
Financing Cash Flow -19,463-20,759-10,377-6,019-14,581-4,285-9,162-11,922-10,199-5,155-3,809-3,729-3,292-5,154-1,815-4,445-5,310-2,433-1,419-3,369
Other Information:
Effect Of Forex Changes On Cash 890673797-425-79-431137-1,013.333-167751831578-154-2956-372-27567641
Net Change In Cash -1,645-2,50720,8304,8853567,22820,3662,642.667-6,9716,5013,576-20,51310,872-6608,8106,649-1,926-5,3465,4011,372
Cash At End Of Period 71,53679,48081,98761,15756,27255,91648,68828,32225,42832,39925,89822,32242,83531,96332,62323,81317,16419,09024,43619,035